By Jason Napodano, CFA Earlier in the week, Neuralstem, Inc (CUR) announced the publication of preclinical data in the journal of Stem Cell Research & Therapy demonstrating that rats transplanted with its spinal cord-derived human neural stem cells, NSI-566, three days after a spinal cord injury at L3 (lumbar 3), showed improvement along several measures of motor function and a reduction of spasticity…
That All May Walk Again!